NCT01789281 2021-06-11Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.NovartisPhase 4 Completed34 enrolled 8 charts
NCT00804336 2016-10-19Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine TumorsDana-Farber Cancer InstitutePhase 1 Completed22 enrolled